Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2403-2016Class I

OraQuick Ebola Rapid Antigen Test, Product Code 3001-2807; Intended for the qualitative detection of antigens...

OraSure Technologies, Inc. / initiated 2016-07-20 / Terminated / root cause: manufacturing process

OraSure Technologies, Inc. began a recall of OraQuick Ebola Rapid Antigen Test, Product Code 3001-2807; Intended for the qualitative detection of antigens for Ebola viruses on . FDA classified it as Class I and gives the reason as "Failed stability testing at 8 months. This lot produced intermittent false negative results for the positive kit control with devices stored at 30C conditions". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2403-2016
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
OraSure Technologies, Inc.
Product
OraQuick Ebola Rapid Antigen Test, Product Code 3001-2807; Intended for the qualitative detection of antigens for Ebola viruses.
Reason for recall
Failed stability testing at 8 months. This lot produced intermittent false negative results for the positive kit control with devices stored at 30C conditions.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
OraSure contacted the sole customer via email and mail (letter dated July 21, 2016) to request return of all the product from the affected lot.
Quantity in commerce
3,075 units
Distribution
Distributed to one customer only in US state of Georgia.
Product codes and lots
Product Code 3001-2807 and the lot number is 6648965. Expiration date October 31, 2016.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2403-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2403-2016Class ITerminatedVoluntary: Firm initiated